Blog
RSS FeedPosted by Michael Wonder on 27 May 2019
Guyon Espiner investigates PHARMAC: NZ diabetes drugs 'third world' - doctor
28 May 2019 - An endocrinologist says New Zealand's type 2 diabetes drugs are 'third world'. Why won't Pharmac fund the ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 27 May 2019
PHARMAC playing 'money game' by not funding drug 49 other countries back - campaigner
27 May 2019 - Pharmac is playing a "money game" while patients are dying, an advocate for a patient group ...
Posted by Michael Wonder on 26 May 2019
PHARMAC switches epilepsy drug against Medsafe advice
27 May 2019 - PHARMAC is making 10,000 people with epilepsy change medication even though Medsafe opposed the move. Guyon Espiner ...
Posted by Michael Wonder on 23 May 2019
Drugs and money
24 May 2019 - An extra $60 million for PHARMAC over the next four years will benefit more than 30,000 New ...
Posted by Michael Wonder on 23 May 2019
Guyon Espiner investigates PHARMAC: the secret list
24 May 2019 - Desperate patients are being left in the dark as to when PHARMAC will fund medicines. Guyon Espiner ...
Posted by Michael Wonder on 22 May 2019
Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club
23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 19 May 2019
Cost of EpiPens putting children at risk, specialists say
19 May 2019 - Children with life-threatening allergies whose families cannot afford to pay for EpiPen auto-injectors are at serious ...
Posted by Michael Wonder on 15 May 2019
Proposal to widen access to pertussis (whooping cough) vaccine
14 May 2019 - PHARMAC is seeking feedback on a proposal to widen access to funded pertussis (whooping cough) vaccine ...
Posted by Michael Wonder on 14 May 2019
PHARMAC publishes list of applications to be considered by PTAC later this month
14 May 2019 - The list includes a number of medicines for patients with breast cancer. ...
Posted by Michael Wonder on 12 May 2019
'It’s absurd' - allergy sufferers beg PHARMAC to fund EpiPens
13 May 2019 - An ice cream factory in the family sounds like every child’s dream. But for Dylan Wright, just ...
Posted by Michael Wonder on 09 May 2019
Proposal for changes to funded vaccines in the National Immunisation Schedule
9 May 2019 - PHARMAC is proposing to make changes to the funding of vaccines in the National Immunisation Schedule ...
Posted by Michael Wonder on 08 May 2019
PTAC recommends the use of pembrolizumab as a first-line treatment for patients with advanced non-small cell lung cancer
8 May 2019 - The focus now shifts to when will the PTAC recommendation be implemented. ...
Posted by Michael Wonder on 08 May 2019
New hope for cancer patients accessing leading-edge unfunded drugs
8 May 2019 - Peter Fergusson, CEO of Leukaemia & Blood Cancer New Zealand is heartened to hear that Pharmac ...